Drug factory · FDA FEI 3002808518

Delpharm Meppel B.V.

Hogemaat 2, Meppel, Netherlands

Netherlands: 1

Problems found, fixed voluntarily at FDA's last inspection, Oct 31, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2014: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
MirabegronTests it Astellas Pharma US, Inc. 0469-5020

FDA inspection history

EndedResultProgramProblems noted
Oct 31, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 26, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 27, 2014No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack.